Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Blood ozonization in patients with mild to moderate COVID-19 pneumonia: a single centre experience.

Internal and emergency medicine - 1 Apr 2021

Tascini Carlo, Sermann Giovanni, Pagotto Alberto, Sozio Emanuela, De Carlo Chiara, Giacinta Alessandro, Sbrana Francesco, Ripoli Andrea, Castaldo Nadia, Merelli Maria, Cadeo Barbara, Macor Cristiana, De Monte Amato

Abstract excerpt

The emerging outbreak of the coronavirus disease 2019 (COVID-19) caused by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) continues to spread worldwide. We prescribed some promising medication to our patients with mild to moderate pneumonia due to SARS-CoV-2, however such drugs as chloroquine, hydrossichloroquine, azithromycin, antivirals (lopinavir/ritonavir, darunavir/cobicistat) and...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Aged
Share to Case-Control Studies

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to COVID-19

Share to Phenotype

Share to Pneumonia, Viral

Share to SARS-CoV-2

Source

Open in PubMed Open full text

Identifiers

PMID: 33131033
DOI: 10.1007/s11739-020-02542-6
PMCID: PMC7603641

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Blood ozonization in patients with mild to moderate COVID-19 pneumonia: a single centre experience.PMID 33131033Read ↗

Pathophysiology of light phenotype SARS-CoV-2 interstitial pneumonia: from histopathological features to clinical presentations.Semantic proximity Read ↗

Fast recovery of COVID-19-induced acute respiratory distress syndrome after hyperbaric oxygen treatment and changes in endoplasmic reticulum (ER) stress response in peripheral monocytes – A randomized-controlled trialSemantic proximity Read ↗

The role of host defences in Covid 19 and treatments thereof.Semantic proximity Read ↗

Red Blood Cells Pathology in Patients with Coronavirus Disease 2019 (COVID-19)Semantic proximity Read ↗

Happy Hypoxia: Higher NO in red blood cells of COVID-19 patientsSemantic proximity Read ↗

Timing of convalescent plasma administration and 28-day mortality for COVID-19 pneumoniaSemantic proximity Read ↗

Environmental Inactivation of SARS-CoV-2 Virus by Liquid HyperoxygenSemantic proximity Read ↗

Bactericidal efficacy of low dose gaseous ozone against clinically relevant multidrug-resistant bacteriaSemantic proximity Read ↗

Efficacy of clarithromycin on COVID-19 pneumonia without oxygen administration; protocol for multicenter, open-label, randomized-controlled, 3-armed parallel group comparison, exploratory trial (CAME COVID study)Semantic proximity Read ↗

Dissolved gases from pressure changes in the lungs elicit an immune response in human peripheral bloodSemantic proximity Read ↗

Effectiveness of extracorporeal blood purification (hemoadsorption) in patients with severe coronavirus disease 2019 (COVID-19)Semantic proximity Read ↗

Potent Activity of a High Concentration of Chemical Ozone against Antibiotic-Resistant BacteriaSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.